← Leaderboards
Nabil F Saba
Emory University
$1,960,185
Attributed
$5,129,214
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,129,214 · 3
By mechanism
UG1$3,626,532 · 1
U01$1,129,452 · 1
R21$373,230 · 1
Top collaborators
- Kristin Higgins3 shared
- Michael Lowe3 shared
- Zhuo Georgia Chen2 shared
- Ashesh Jani2 shared
- Nicole Cherie Schmitt2 shared
- Charles A Staley2 shared
Most similar at Emory University
Same institution · by research overlap
- Timothy L Lash$9,334,509
- Charles A Staley$2,799,932
- Suresh S Ramalingam$10,859,222
- Kristin Higgins$1,206,133
- Jonathan Beitler$954,151
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDesignCaringPlayBaseLeadFundingSiteClinical TrialsFacultyDiagnosisAdvisory CommitteesAwardEastern Cooperative Oncology GroupFellowshipCommunity Clinical Oncology ProgramCancer Center Support GrantComprehensive Cancer CenterAmerican College Of Radiology Imaging NetworkCancer ImagingCancer PreventionClinical Trials NetworkCause Of DeathCareer
Grant awards (9)
Winship National Clinical Trials Network Lead Academic Participating Site$682,746
UG1 · FY2025 · CA · contact PI
Winship National Clinical Trials Network Lead Academic Participating Site$762,746
UG1 · FY2024 · CA · contact PI
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients$543,623
U01 · FY2024 · DC
Winship National Clinical Trials Network Lead Academic Participating Site$718,680
UG1 · FY2023 · CA
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients$585,829
U01 · FY2023 · DC
Winship National Clinical Trials Network Lead Academic Participating Site$718,680
UG1 · FY2022 · CA
Winship National Clinical Trials Network Lead Academic Participating Site$743,680
UG1 · FY2021 · CA
A Novel genomics-based approach to differentiate HPV-positive and -negative HNC$169,650
R21 · FY2015 · CA · contact PI
A Novel genomics-based approach to differentiate HPV-positive and -negative HNC$203,580
R21 · FY2014 · CA · contact PI